FDA Drug Recalls

Recalls / Class II

Class IID-170-2013

Product

Belladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr, USP 0.0065 mg) with Phenobarbital (USP 16.2 mg) Tablets, packaged in a) 1000-count tablets per bottle (NDC 0143-1140-10; b) 5000-count tablets per bottle (NDC 143-1140-51); Rx only, Manufactured by: West-ward Pharmaceutical Corp. Eatontown, NJ 07724

Affected lot / code info
Lot #: 69099A, 69099B, Exp 08/15

Why it was recalled

Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.

Recalling firm

Firm
West-ward Pharmaceutical Corp.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
465 Industrial Way W, N/A, Eatontown, New Jersey 07724-2209

Distribution

Quantity
6,511 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-01-07
FDA classified
2013-02-27
Posted by FDA
2013-03-06
Terminated
2015-01-21
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-170-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls